Ist pentapeptide-61 in der Schwangerschaft sicher?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment for pentapeptide-61 was identified in available regulatory sources. No peer-reviewed reproductive or developmental toxicity data specific to pentapeptide-61 were found. Peptides of this size are generally polar and have low systemic absorption after topical use, so default hazard/mechanism/exposure ratings are 0. Sources consulted: ECHA Annex VI (no entry), CIR (no specific assessment), PubMed (no reproductive/developmental studies found), CosIng/PubChem entries show cosmetic peptide identity only.
Related ingredients
Frequently asked questions
- Ist pentapeptide-61 in der Schwangerschaft sicher?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment for pentapeptide-61 was identified in available regulatory sources. No peer-reviewed reproductive or developmental toxicity data specific to pentapeptide-61 were found. Peptides of this size are generally polar and have low systemic absorption after topical use, so default hazard/mechanism/exposure ratings are 0. Sources consulted: ECHA Annex VI (no entry), CIR (no specific assessment), PubMed (no reproductive/developmental studies found), CosIng/PubChem entries show cosmetic peptide identity only.
- Ist pentapeptide-61 während des Stillens sicher?
- No evidence of reproductive or lactation-specific toxicity or mechanism for pentapeptide-61 in SCCS/CIR/ECHA or peer-reviewed literature. No harmonised classification. Given expected low dermal absorption of short peptides, systemic exposure to lactating parent and transfer into breast milk is considered negligible based on available information.
- Ist pentapeptide-61 sicher für Babyhaut?
- No infant-specific safety or developmental toxicity data identified. Peptides this size are generally poorly absorbed through intact adult skin (adult exposure rated 0), but infant skin has higher permeability; following guidance, exposure for baby skin is increased by +1 (to 1) due to possible measurable absorption in infants. No mechanistic or hazard evidence for reproductive/developmental effects specific to infants was found.
- Wie bewertet VeriMom pentapeptide-61?
- VeriMom bewertet pentapeptide-61 mit 100/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu pentapeptide-61?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu pentapeptide-61 basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.